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Available online 4 August 2016The salmon louse Lepeophtheirus salmonis (Krøyer, 1837) is an ectoparasite causing infections of wild and farmed
Atlantic salmon (Salmo salar L.) in the Northern hemisphere.While L. salmonis control at commercial mariculture
sites increasingly employs non-medicinal approaches, such as cage designs reducing infection rates and biolog-
ical control through cleaner ﬁsh, anti-parasitic drugs are still a requirement for effective ﬁsh health care. With
only a limited range of salmon delousing agents available, all of which have been in use for more than a decade,
drug resistance formation has been reported for different products. Successful resistance management requires
reliable susceptibility assessment, which is usually achieved through L. salmonis bioassays. These tests involve
the exposure of parasites to different drug concentrations and require signiﬁcant numbers of suitable L. salmonis
stages. The present study reports an alternative bioassay that is based on time-to-response toxicity analyses and
can be carried out with limited parasite numbers. The assay determines themedian effective time (ET50), i.e., the
time required until impaired swimming and/or attachment behaviour becomes apparent in 50% of parasites, by
conducting repeated examinations of test animals starting at the timepointwhere exposure to a set drug concen-
tration commences. This experimental approach further allows the estimation of the apparent drug susceptibility
of individual L. salmonis by determining their time to response, whichmay prove useful in experiments designed
to elucidate associations between genetic factors and the drug susceptibility phenotype of parasites. Three labo-
ratory strains of L. salmonis differing in susceptibility to emamectin benzoate were characterised using standard
24 h bioassays and time-to-response toxicity assays. While both the median effective concentration (EC50) and
the ET50 showed variability betweenexperimental repeats, both types of bioassay consistently discriminated sus-
ceptible and drug-resistant L. salmonis laboratory strains.
Statement of relevance: Infections by sea lice cause signiﬁcant costs to the global salmon farming industry, which
have been estimated to exceed €300million per year worldwide. Control of sea lice still relies to a signiﬁcant ex-
tent on chemical delousing; however, chemical control is threatened by resistance formation. Resistance can be
combated by rotation between different drugs and strategic implementation of non-medicinal strategies. How-
ever, resistance management requires reliable and feasible methods of susceptibility assessment.
The present study is a technical note introducing a novel approach to susceptibility assessments in sea lice. The
method can be applied in susceptibility assessments on farms,where it offers the advantage of a reduced require-
ment of parasites for testing. In addition, the novelmethod allows deriving the times of parasite require to show a
response after drug treatment has started, thus providing a variable characterizing the drug susceptibility pheno-
type of individual parasites. Accordingly, the bioassay approach presented here will be useful for studies aiming
at unravelling the genetic determinants of drug resistance.an effective c
; LT50, media
. This is an o© 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Keywords:
Parasite
Drug susceptibility
Emamectin benzoate
Sea lice
Salmon delousing agentoncentration; LC50,
n lethal time; PEG
pen access article under1. Introduction
Sea lice (Caligidae: Copepoda) are marine ﬁsh ectoparasites feeding
on the host's mucus and skin tissues (Boxaspen, 2006). Sea louse
infections of farmed Atlantic salmon (Salmo salar) mostly involve
Lepeophtheirus salmonis (salmon louse) and Caligus elongatus in the
Northern hemisphere, and Caligus rogercresseyi in Chile (Costello,the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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erinary drugs, supplemented by farmmanagement measures (Costello,
2009) andnon-medicinal approaches such as the deployment of cleaner
ﬁsh (Sayer et al., 1996) and modiﬁed cage designs reducing the likeli-
hood of infection (Stien et al., 2016).
Only a restricted range of licensed anti-sea louse drugs are currently
available (Burridge et al., 2010). The continued use of the same or a few
types of control agents, however, can favour the development of drug
resistance in parasites (Denholm et al., 2002). Drug resistance is well
documented in L. salmonis, and compounds for which loss of efﬁcacy
has been reported include the organophosphates dichlorvos and
azamethiphos (Jones et al., 1992; Kaur et al., 2015; Roth et al., 1996),
the pyrethroid deltamethrin (Sevatdal and Horsberg, 2003), the non-
speciﬁc oxidising agent hydrogen peroxide (Treasurer et al., 2000)
and the macrocyclic lactone emamectin benzoate (EMB) (Lees et al.,
2008). Resistance to different drugs has further been found in C.
rogercresseyi (Agusti et al., 2016; Bravo et al., 2010). Accordingly, there
is an urgent need for efﬁcient resistance prevention and management
strategies in sea lice (Aaen et al., 2015).
A key requirement for such effective sea louse control strategies is an
accurate assessment of the drug susceptibility status of sea louse popu-
lations. Such assessments are usually achieved by conducting bioassays,
which typically involve subjecting batches of preadult or adult parasites
to a dilution series of the drug (Sevatdal and Horsberg, 2003; Westcott
et al., 2008). The internal exposure of an aquatic organism taking up a
toxicant fromwater will increase bothwith increasing toxicant concen-
tration and increasing length of exposure. Traditional aquatic bioassays
typically employ different toxicant concentrations to achieve gradually
varied exposures, while keeping the length of the exposure period con-
stant. Results are expressed as the median lethal or median effective
concentration (LC50, EC50), i.e., the concentration theoretically causing
a toxic effect in 50% of the tested population. In an alternative approach
called time-to-response toxicity analysis, gradual exposure levels are
achieved by combining a ﬁxed toxicant concentration with variable ex-
posure periods. In this approach, the susceptibility of the population to
the toxicant is expressed as the median lethal or effective time (LT50,
ET50) (Robertson and Preisler, 1991). Time-to-response bioassays have
been used in susceptibility assessments of terrestrial arthropod pests
(Robertson and Preisler, 1991) and ecotoxicity studies in aquatic inver-
tebrates and ﬁsh (Pascoe and Edwards, 1989; Rand, 2008).
The availability of sea louse stages suitable for bioassays can be re-
stricted at production sites. Alternative bioassays involving only one
drug concentration and a ﬁxed exposure period have been proposed
to allow for drug susceptibility assessment under such circumstances
(Helgesen and Horsberg, 2013a; Whyte et al., 2013). While single-
dose bioassays can be highly useful as a tool in ﬁsh healthmanagement,
their ability to resolve susceptibility differences between parasite popu-
lations is by design limited. Time-to-response toxicity analyses could
provide a complementary approach allowing characterisation of the
susceptibility status at greater depth when sea louse availability is re-
stricted. In addition to supporting veterinary decisions on ﬁsh farms,
drug susceptibility assessments in sea lice are central to experimental
plans aiming at identifying genetic determinants of drug resistance,
which often require the determination of the susceptibility phenotypes
of individuals (Besnier et al., 2014). Differentiation between susceptible
and resistant parasites has been previously achieved by rating toxic re-
sponses following exposure to a diagnostic drug concentration for a set
time period (Ljungfeldt et al., 2014). Using a similar approach, but addi-
tionally implementing repeated observations to determine the time to
response for individual parasites, would permit a more graduated char-
acterisation of the drug susceptibility phenotype than achievable with a
test design employing a one concentration/one exposure time cut-off
criterion to deﬁne resistance/susceptibility.
The aim of the present study was to investigate the potential of
time-to-response toxicity analyses as an alternative approach to
conducting sea louse drug sensitivity assessments. Time-to-responsetoxicity analyses were compared to standard bioassays with respect to
their ability to differentiate between well-characterised laboratory
strains of L. salmonis showing different degrees of resistance to the
salmon delousing agent EMB.
2. Materials and methods
2.1. Salmon louse (L. salmonis) strains and husbandry
Three L. salmonis laboratory-maintained strains established from
ﬁeld isolates of egg strings without further selection in the laboratory
were used in this study. The drug-susceptible strain IoA-00 (previously
called “S″) (Heumann et al., 2012) was established in 2003 from a Scot-
tish farm site where no chemical control agents other than hydrogen
peroxide had been used. The EMB-resistant strain IoA-01 (previously
called “PT” or “R”) (Heumann et al., 2012, 2014) and themulti-resistant
strain IoA-02, which is hyposensitive to both EMB and deltamethrin,
were created in December 2008 and September 2011, respectively,
from other Scottish sites where there had been reports of variable treat-
ment efﬁcacies. These strains have since been cultured under identical
laboratory conditions using Atlantic salmon as host ﬁsh, as described
in detail elsewhere (Heumann et al., 2012). To propagate cultures, L.
salmonis egg strings were collected from gravid females and allowed
to hatch and develop to infective copepodids, which were used to inoc-
ulate tanks containing fresh host ﬁsh. To collect L. salmonis, host ﬁsh
were either euthanised under a UK Home Ofﬁce approved Schedule 1
method, or anaesthetised with 100 mg L−1 2-phenoxyethanol (99%;
Sigma-Aldrich, Dorset, UK) in seawater for 3min. Previous experiments
assessing the effect of anaesthesia on bioassay results did notﬁnd signif-
icant differences between the two sea lice collection methods (data not
shown). Parasites were removed from ﬁsh into clean aerated seawater
using ﬁne forceps, and ﬁsh were transferred into clean seawater with
aeration for recovery. Infection ratesweremaintained at levels compat-
ible with good ﬁsh welfare according to MERL Good Laboratory Practise
(GLP) Standard Operating Procedure (SOP) protocols. All laboratory in-
fectionswere carried out under UKHomeOfﬁce licence and appropriate
veterinary supervision.
2.2. Standard bioassays
Experiments used adult male or preadult II female L. salmonis. After
collection from host ﬁsh, parasites were allowed to recover for 2–4 h
in ﬁltered aerated seawater at 12 °C before use in bioassays. Exposures
were performed in a temperature-controlled incubator set to 12 °C,
using 150 mL plastic Petri dishes holding 70 mL of exposure solutions
and containing ten sea lice. EMB (technical grade, a gift from MSD Ani-
mal Health)was solubilised using polyethylene glycol of a number aver-
age molecular weight (Mn) of 300 (PEG 300, pH. Eur., Merck Chemicals,
UK) before being diluted in seawater. Exposure solutions contained a
ﬁnal concentration of 0.05% (v/v) PEG 300. Each test comprised a geo-
metrical dilution series of EMB of at least ﬁve concentrations in addition
to seawater and solvent controls, the latter containing 0.05% (v/v) PEG
300. Sea lice were assigned to treatments randomly. At least two repli-
cate Petri dishes were used per combination of strain and drug or con-
trol treatment. After 24 h of exposure, sea lice were visually examined
and rated according to their attachment and mobility behaviour. Prior
to rating, beakers were re-labelledwith codes by laboratory staff not in-
volved in the recording of experimental outcomes to allow for observer-
blinded rating. In experiments conducted in 2011 and before, salmon
lice were rated as normally motile (unaffected) or immotile (affected)
upon visual examination and stimulation with a ﬁne brush (Heumann
et al., 2012). Later experiments used rating criteria initially proposed
by Sevatdal and Horsberg (2003) andWestcott et al. (2008) and modi-
ﬁed by Igboeli et al. (2012), where parasites are rated “live”when ﬁrmly
attached to the surface of the Petri dish or swimming normally, “weak”
when swimming irregularly and failing to attach to surfaces ﬁrmly
Fig. 1. Standard emamectin benzoate (EMB) bioassay with Lepeophtheirus salmonis.
Symbols represent the average behavioural toxic response of at least two batches of ten
animals, recorded after 24 h of exposure to EMB in plastic Petri dishes. A, EMB toxicity
in salmon louse strains IoA-00 and IoA-01. B, EMB toxicity in strains IoA-00 and IoA-02.
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when incapable of swimming away or attaching (animals may twitch
appendages or move uncoordinatedly in a close circle) and “dead”
when showing nomovements in extremities, gut or other organs as ap-
parent from examination under a microscope. Using this set of criteria,
parasites were considered unaffected when rated “live” or “weak” and
affected when rated “moribund” or “dead”. Bioassays were considered
invalid if N10% of parasites in control treatments were deemed affected.
2.3. Time-to-response bioassays
Sea lice were exposed for 24 h to 400 μg L−1, 800 μg L−1 or
1200 μg L−1 of EMB, using similar general procedures and involving
the same types of controls and levels of replication as described in Sec-
tion 2.1.2. At set time intervals throughout the exposure period, para-
sites were visually examined and rated as described in Section 2.1.2.
Typically, this involved hourly examinations for the beginning of the ex-
posure period (1–15 h after addition of toxicants) followed by further
examinations at 18, 21 and 24 h. Experimentation thus involved repeat-
ed examination of the same sea lice. In time-to-response bioassays, the
main factor controlling toxic response is exposure time, which cannot
be concealed to the experimenter by coded labelling. To ensure impar-
tial rating in these assays, animals were rated by a second observer un-
aware of the nature of the experiment at selected time points. Ratings of
immotile parasites per Petri dish never differed by more than one be-
tween observers. All other experimental conditions were identical to
those described in Section 1.1.2 for the standard bioassay.
2.4. Statistics
In standard bioassays, median effective concentrations (EC50) of
EMB and 95% conﬁdence intervals were generally calculated by probit
analysis using the statistical programme Minitab 16.1.0 (Minitab Inc.).
In cases where data were not suitable for probit analysis, the trimmed
Spearman–Karber method was used to derive the EC50 and 95% conﬁ-
dence limits (Hamilton et al., 1977). In time-to-response bioassays, me-
dian effective times (ET50) and 95% conﬁdence intervals were estimated
using the survival time module of Minitab, assuming a log-normal dis-
tribution. In all tests associated to the above estimations, results were
considered signiﬁcant if the probability value (P) was b0.05.
3. Results
3.1. Standard bioassay
Three laboratory-maintained salmon louse strains differing in sus-
ceptibility to EMB were used in this study. When applied at concentra-
tions N100 μg L−1, EMB induced behavioural toxic responses in strain
IoA-00 in a concentration-dependent manner (Fig. 1). Higher EMB con-
centrations were required to provoke similar toxic responses in strains
IoA-01 and IoA-02 (Fig. 1). Strain differences in EMB susceptibility are
illustrated bymedian effective concentrations (EC50) obtained in differ-
ent experiments, with estimates for the EC50 in adult males ranging
from 74.3 to 159.3 μg L−1 for IoA-00, from 553 to 780 μg L−1 in IoA-
01 and 445 to 675 μg L−1 in IoA-02 (Table 1). With strain IoA02, pre-
adult II females were signiﬁcantly more susceptible to EMB than adult
males. By contrast, gender differences in EMB susceptibility were not
signiﬁcant in strain IoA-00 (Table 1).
3.2. Time-to-response bioassay
To investigate the potential of time-to-response salmon louse bioas-
says to assess strain and gender differences in EMB susceptibility, exper-
iments were ﬁrst conducted using an exposure concentration of
800 μg L−1 (Fig. 2). Apparent response levels in exposed parasites in-
creased in a time-dependent fashion, allowing the median effectivetime (ET50) to be derived for the populations tested (Table 2). While
ET50 values determined at an exposure level of 800 μg L−1 EMB showed
some variation between experiments, bioassays with male salmon lice
consistently found greater ET50 values in strains IoA-01 and IoA-02
than strain IoA-00 (Table 2). During exposure to 800 μg L−1 EMB, re-
sponse levels in the IoA-00 strain increased very rapidly after ﬁrst
signs of toxicity became apparent, with few or no partial responses
being observed at set examination times (Fig. 2). This precluded the es-
timation of 95% conﬁdence limits in some experiments (Table 2). Subse-
quent time-to-response experiments employed EMB levels of 400 or
1200 μg L−1. Changing the EMB exposure concentration within the
above limits had little effect on the time course of toxicity in the IoA-
00 strain, as apparent from ET50 values showing overlapping 95% conﬁ-
dence intervals (Table 2). Similarly, ET50 values for IoA-01 males were
similar between trials using 800 and 1200 μg L−1 of EMB (Table 2). By
contrast, ET50 values for IoA-02 females at 400 μg L−1 were signiﬁcantly
greater than at 800 μg L−1 EMB. In exposures with 400 μg L−1 EMB, no
ET50 could be determined for IoA-02males, as these salmon lice failed to
show apparent signs of toxicity within the 24 h experiment (Table 2).
4. Discussion
The assessment of drug susceptibility of salmon louse populations
causing farm infections is essential to provide information to ﬁsh health
professionals and aid the identiﬁcation of effective therapeutic options.
Susceptibility assessments are commonly based on the performance of
salmon louse bioassays, which involve the exposure of batches of para-
sites to drug concentrations forming a geometrical series.While salmon
louse bioassays are well standardised and ﬁeld-tested (Sevatdal and
Horsberg, 2003;Westcott et al., 2008), their requirement for signiﬁcant
numbers of test animals can be problematic in situations where the
Table 1
Susceptibility of Lepeophtheirus salmonis strains to emamectin benzoate. The toxicity of EMB to deﬁned parasite stages of different laboratory-maintained strains was determined in 24 h
bioassays. Results are expressed as EMB median effective concentrations (EC50), determined by probit analysis except where noted otherwise.
Strain Sex/stage Response rate in controls EC50 (μg L−1)
(95% conﬁdence limits)
Date of experiment
IoA-00 Male, adult 10% 159.3 (145.4–175.6)1 01/2011
Male, adult 0% 74.3 (59.0–94.1)2 05/2011
Male, adult 0% 92.4 (83.2–106.7) 03/2015
Female, preadult II 0% 78.6 (70.0–88.3) 03/2015
IoA-01 Male, adult 0% 695.5 (583.5–841.1)1 11/2010
Male, adult 0% 780.3 (642.9–967.4)2 05/2011
Male, adult 2.5% 553.0 (486.1–624.7) 07/2011
IoA-02 Male, adult 0% 949.8 (767.8–1204.8)3 11/2011
Male, adult 0% 675.0 (618.0–738.0)4 10/2014
Female, preadult II 0% 335.3 (277.0–409.4)3 11/2011
Female, preadult II 0% 355.1 (289.9–521.1) 03/2015
1 Data shown in Fig. 1A.
2 Data from Carmichael et al. (2013).
3 Data shown in Fig. 1B.
4 Trimmed Spearman–Karber statistics.
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with ﬁve test concentrations and one control and involving duplicate
experimental and control treatments with ten animals eachwill require
120 parasites. By comparison, only 40 parasites are required in time-to-
response bioassay at the same level of replication. While the time-to-
response bioassay described here is more labour intensive than single-
dose bioassays involving a single exposure time (Helgesen and
Horsberg, 2013a; Whyte et al., 2013), the time-to-response bioassay
characterises the drug susceptibility phenotype of the given parasite
population at greater resolution. Thus, the time-to-response bioassayFig. 2. Time-to-response bioassay with Lepeophtheirus salmonis. Symbols represent the
average behavioural toxic response of at least ten animals. Salmon lice were exposed to
800 μg L−1 of emamectin benzoate (EMB) for a total period of 24 h, during for which
repeated observations of parasite motility and attachment behaviour were made. A,
EMB toxicity in salmon louse strains IoA-00 and IoA-01; B, EMB toxicity in strains IoA-
00 and IoA-02.can be expected to complement existing methods of drug susceptibility
assessment in salmon lice with deployment of the new bioassay de-
pending on context of the study. In addition to the potential for imple-
mentation of this novel bioassay in the assessment of farm site
infections, the time-to-response bioassay is capable of providing esti-
mates of the drug susceptibility of individual parasites, which suggests
its usefulness in the context of analysing molecular responses of sea
lice to anti-parasitic drugs.
While salmon lice parasitising EMB-treated ﬁsh experience drug ex-
posure both through contact with and ingestion of mucous and skin tis-
sues, parasites are exposed solely through the aqueous route in 24 h
bioassays, complicating the prediction of treatment efﬁciencies from
bioassay ﬁndings. In an earlier study, EMB medication (50 μg kg−1,
seven days) of experimentally infected salmon resulted in 98% salmon
lice clearance for strain IoA-00 parasites by day 21 after the start of
treatment cycle but had no effect on IoA-01 salmon lice (SARF, 2012).
Similarly, no clearance of strain IoA-02 was observed from a standard
EMB treatment cycle (data not shown). Accordingly, the levels of resis-
tance of parasite strains used in this study are clinically relevant. The
fact that the time-to-response bioassay described in this work is able
to differentiate between the above EMB-resistant strains and a suscep-
tible reference strain suggests the usefulness of the time-to-response
bioassay for susceptibility assessments.
Salmon louse bioassays have been initially deﬁned using a parasite
behaviour rating scale of three categories (Sevatdal and Horsberg,
2003; Westcott et al., 2008). According to this scale, animals are rated
“live” at the end of the test when they attach ﬁrmly to the Petri dish
or show normal locomotive behaviour, such as swimming in a straight
line. By contrast, “moribund” salmon lice show impaired motility be-
haviours, ranging from irregular swimming to inability to move, as
well asweak adhesion. Parasites are rated “dead” if they shownomove-
ment in the extremities or the gut (Sevatdal and Horsberg, 2003;
Westcott et al., 2008). More recently, different groups have adopted a
four category rating scheme, involving a more narrow deﬁnition of
“moribund”, which now includes only immotile parasites still showing
twitching of appendages but not irregular swimmers, and the new cat-
egory “weak”, which comprises parasites displaying irregular swim-
ming or weak attachment to the Petri dish wall (Igboeli et al., 2012;
Saksida et al., 2013). In the present study, this four criteria scale was
adapted in experiments carried out in 2012 and thereafter, while earlier
experiments used the three-category scale (Sevatdal and Horsberg,
2003;Westcott et al., 2008). The change in rating criteria had little effect
on the outcome of most bioassays but markedly reduced the number
tests that were invalid due to excessive response levels in controls,
which were mostly due to parasites showing weak attachment behav-
iour but only slightly impaired swimming. The present investigation
Table 2
Toxic response of Lepeophtheirus salmonis strains to emamectin benzoate in time-to-response bioassays. Toxicity is expressed as the median effective time (ET50).
Date EMB
(μg L-1)
ET50 (h)
(95% conﬁdence limits)
IoA-00 IoA-01 IoA-02
Males Females Males Males Females
12/2011 800 5.861 4.03 (3.67–4.43) 21.36 (16.82– 27.13)
07/20122 800 6.77 (6.08–7.54) 28.46 (15.94–50.84)
07/2012 1200 5.72 (5.07–6.44) 25.66 (17.49–37.65)
03/20153 800 6.001 5.081 13.18 (10.51–16.51) 9.98 (8.99–11.08)
07/2015 400 6.82 (6.33–7.35) 5.21 (4.68–5.81) N 244 16.50 (13.91–19.56)
1 Data do not allow calculation of 95% conﬁdence limits.
2 Data set shown in Fig. 2A.
3 Data set shown in Fig. 2B.
4 Data do not allow calculation of ET50.
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methodologies, so that changes in rating scale do not affect the study's
ﬁndings.
EMB EC50 values obtained in different experiments with male para-
sites ranged from 74.3 to 159.3 μg L−1 for IoA-00 and 553.0 to
780.3 μg L−1 for IoA-01. The lower EMB EC50 of 289.0 μg L−1 obtained
for IoA-01 males in a previous study has been excluded from data con-
sidered in this study, as DMSOwas used as solvent carrier in that study
(Heumann et al., 2014), which may have inﬂuenced toxicity
(Tanneberger et al., 2010). While results obtained in the current study
illustrate variability among EC50 estimates, standard bioassays consis-
tently differentiated the EMB-resistant strains IoA-01 and IoA-02 from
the susceptible strain IoA-00. Paralleling the results obtained in the
present study, Espedal et al. (2013) observed consistent strain differ-
ences in EMB susceptibility despite between-test variability in absolute
EMB bioassay estimates. Similar to standard bioassays, the time-to-re-
sponse bioassay introduced in the present report displays a certain de-
gree of variation in ET50 values between repeated experiments. Factors
that might be responsible for the variability observed in this study in-
clude seasonal effects, as well as variability in the actual test concentra-
tions of EMB, known for its hydrophobicity. An earlier study from this
laboratory detected 49.7% of a nominal EMB concentration of
200 μg L−1 3 h after the start of exposures (Carmichael et al., 2013).
Similarly, in another study (Helgesen and Horsberg, 2013b), 48.9% of
an nominal concentration of 150 μg L−1 EMB was detected in the sea-
water phase at the end of 24 h salmon louse bioassays performed in
high-density polyethylene dishes. In the same study, recoveries were
slightly less in tests using glass dishes (41.9%) and substantially inferior
when using Teﬂon™ or silanised glass containers (27.4% and 24.0%, re-
spectively) (Helgesen and Horsberg, 2013b).
4.1. Conclusion
In conclusion, the present study describes a novel salmon louse bio-
assay based on time-to-response analyses, which requires less test ani-
mals than current standard salmon louse bioassays. Our results indicate
that time-to-response bioassays are powerful tools to assess the suscep-
tibility of salmon louse populations to control agents such as EMB, par-
ticularly in situations where the availability of test animals is restricted.
A further advantage of this novel bioassay is its ability to provide
estimates of the drug susceptibility of individual parasites, which is ex-
pected to be useful in the context of analysing molecular responses of
salmon lice to anti-parasitic drugs.
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